Management of Severe Graves' Hyperthyroidism in Pregnancy Following Immune Reconstitution Therapy in Multiple Sclerosis.

Sara Salehi HammerstadElisabeth G CeliusHenrik HusbyIngvild M SørensenIngrid E Norheim

Published in: Journal of the Endocrine Society (2021)

Multiple sclerosis patients treated with ALZ may develop severe Graves' disease with an increased risk of both fetal and neonatal thyrotoxicosis. Close follow-up with a multidisciplinary approach is needed to ensure a healthy outcome.

Keyphrases

multiple sclerosis
early onset
white matter
preterm birth
drug induced
stem cells
quality improvement
cell therapy